Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma
出版年份 2013 全文链接
标题
Pronecrotic mixed lineage kinase domain-like protein expression is a prognostic biomarker in patients with early-stage resected pancreatic adenocarcinoma
作者
关键词
-
出版物
CANCER
Volume 119, Issue 17, Pages 3148-3155
出版商
Wiley
发表日期
2013-05-30
DOI
10.1002/cncr.28144
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- RIP3 expression induces a death profile change in U2OS osteosarcoma cells after 5-ALA-PDT
- (2015) Isabelle Coupienne et al. LASERS IN SURGERY AND MEDICINE
- Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinoma
- (2012) J. B. Bachet et al. ANNALS OF ONCOLOGY
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- An analysis of human equilibrative nucleoside transporter-1, ribonucleoside reductase subunit M1, ribonucleoside reductase subunit M2, and excision repair cross-complementing gene-1 expression in patients with resected pancreas adenocarcinoma
- (2012) Sarah B. Fisher et al. CANCER
- Systemic treatment of advanced pancreatic cancer
- (2012) Volker Heinemann et al. CANCER TREATMENT REVIEWS
- Mixed Lineage Kinase Domain-like Protein Mediates Necrosis Signaling Downstream of RIP3 Kinase
- (2012) Liming Sun et al. CELL
- High Expression of CX3CL1/CX3CR1 Axis Predicts a Poor Prognosis of Pancreatic Ductal Adenocarcinoma
- (2012) Xianhui Xu et al. JOURNAL OF GASTROINTESTINAL SURGERY
- New components of the necroptotic pathway
- (2012) Zhenru Zhou et al. Protein & Cell
- Differential Expression of ERCC1 in Pancreas Adenocarcinoma: High Tumor Expression is Associated with Earlier Recurrence and Shortened Survival after Resection
- (2011) Shishir K. Maithel et al. ANNALS OF SURGICAL ONCOLOGY
- Systematic review of immunohistochemical biomarkers to identify prognostic subgroups of patients with pancreatic cancer
- (2011) D. Ansari et al. BRITISH JOURNAL OF SURGERY
- Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer
- (2011) X. Liu et al. CANCER RESEARCH
- Many stimuli pull the necrotic trigger, an overview
- (2011) N Vanlangenakker et al. CELL DEATH AND DIFFERENTIATION
- Tissue Biomarkers for Prognosis in Pancreatic Ductal Adenocarcinoma: A Systematic Review and Meta-analysis
- (2011) N. B. Jamieson et al. CLINICAL CANCER RESEARCH
- The Ripoptosome, a Signaling Platform that Assembles in Response to Genotoxic Stress and Loss of IAPs
- (2011) Tencho Tenev et al. MOLECULAR CELL
- GLUT-1 Expression in Pancreatic Neoplasia
- (2011) Olca Basturk et al. PANCREAS
- A DNA Damage Response Screen Identifies RHINO, a 9-1-1 and TopBP1 Interacting Protein Required for ATR Signaling
- (2011) C. Cotta-Ramusino et al. SCIENCE
- ERCC1: impact in multimodality treatment of upper gastrointestinal cancer
- (2010) Ralf Metzger et al. Future Oncology
- Glycogene Expression Alterations Associated with Pancreatic Cancer Epithelial-Mesenchymal Transition in Complementary Model Systems
- (2010) Kevin A. Maupin et al. PLoS One
- The Role of the Kinases RIP1 and RIP3 in TNF-Induced Necrosis
- (2010) P. Vandenabeele et al. Science Signaling
- FKBP51 Affects Cancer Cell Response to Chemotherapy by Negatively Regulating Akt
- (2009) Huadong Pei et al. CANCER CELL
- DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
- (2009) Christine A. Iacobuzio-Donahue et al. JOURNAL OF CLINICAL ONCOLOGY
- A Genome-wide siRNA Screen Reveals Diverse Cellular Processes and Pathways that Mediate Genome Stability
- (2009) Renee D. Paulsen et al. MOLECULAR CELL
- Human Equilibrative Nucleoside Transporter 1 Levels Predict Response to Gemcitabine in Patients With Pancreatic Cancer
- (2008) James J. Farrell et al. GASTROENTEROLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started